A white-knuckle ride of open COVID drug discovery.

von Delft F., Calmiano M., Chodera J., Griffen E., Lee A., London N., Matviuk T., Perry B., Robinson M., von Delft A.

DOI

10.1038/d41586-021-01571-1

Type

Journal article

Publication Date

2021-06-01T00:00:00+00:00

Volume

594

Pages

330 - 332

Total pages

2

Keywords

Drug discovery, Medical research, Research management, SARS-CoV-2, Animals, Antiviral Agents, COVID-19, Clinical Trials as Topic, Cooperative Behavior, Coronavirus 3C Proteases, Crowdsourcing, Crystallography, X-Ray, Drug Discovery, Drug Evaluation, Preclinical, Drug Repositioning, Goals, Humans, International Cooperation, Israel, Open Access Publishing, SARS-CoV-2, Social Media, Synchrotrons, Time Factors, United Kingdom, Videoconferencing, Volunteers, World Health Organization, COVID-19 Drug Treatment

Permalink More information Close